3-(3-Fluorophenyl)piperidine--hydrogen chloride (1/1) → HCID 86687677、化合物

HRID 1473612ノート

反応式

HRID 1473612 の反応式
Cl[C:2]1[C:11]2[C:6](=[CH:7][C:8]([S:12]([NH:15][C:16]3[CH:21]=[CH:20][N:19]=[CH:18][N:17]=3)(=[O:14])=[O:13])=[CH:9][CH:10]=2)[CH:5]=[CH:4][N:3]=1.[Cl-].C(C1C=CC=C(CCC)C=1[N+]1C=CN(C2C(CCC)=CC=CC=2CCC)C=1)CC.Cl.[F:53][C:54]1[CH:55]=[C:56]([CH:60]2[CH2:65][CH2:64][CH2:63][NH:62][CH2:61]2)[CH:57]=[CH:58][CH:59]=1.CC(C)([O-])C.[Na+]>C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd].[Pd].O1CCOCC1>[F:53][C:54]1[CH:55]=[C:56]([CH:60]2[CH2:65][CH2:64][CH2:63][N:62]([C:2]3[C:11]4[C:6](=[CH:7][C:8]([S:12]([NH:15][C:16]5[CH:21]=[CH:20][N:19]=[CH:18][N:17]=5)(=[O:14])=[O:13])=[CH:9][CH:10]=4)[CH:5]=[CH:4][N:3]=3)[CH2:61]2)[CH:57]=[CH:58][CH:59]=1

参加物

7

反応物 4

HCID 190956263-(3-Fluorophenyl)piperidine--hydrogen chloride (1/1)HCID 223147471,3-Bis(2,6-di-1-propylphenyl)imidazolium chlorideHCID 23676156Sodium t-butoxideHCID 866876591-chloro-N-(pyrimidin-4-yl)isoquinoline-6-sulfonamide

生成物 1

HCID 86687677HCID 86687677、化合物

試薬・触媒・溶媒 2

HCID 9811564Bis(dibenzylideneacetone)palladium触媒HCID 312751,4-Dioxane溶媒

反応条件

温度
130 °C

実験手順

A vial was charged with 1-chloro-N-(pyrimidin-4-yl)isoquinoline-6-sulfonamide (Intermediate GG; 0.200 g, 0.624 mmol), Pd2(dba)3 (0.029 g, 0.031 mmol), 1,3-bis(2,6-di-1-propylphenyl)imidazolium chloride (0.027 g, 0.062 mmol), 3-(3-fluorophenyl)piperidine hydrochloride (0.202 g, 0.935 mmol) and sodium tert-butoxide (0.240 g, 2.494 mmol). Dioxane (6.24 ml) was added and the reaction was flushed with argon and stirred at 130° C. for one hour. The reaction was diluted with ethyl acetate and washed with water. The aqueous layer was extracted with ethyl acetate, and the combined organic layers were dried with sodium sulfate, filtered, and concentrated. The material was purified via column chromatography (RediSep Gold 40 g, gradient elution 0-10% MeOH:DCM) to afford 1-(3-(3-fluorophenyl)piperidin-1-yl)-N-(pyrimidin-4-yl)isoquinoline-6-sulfonamide as a light yellow solid. 1H NMR (400 MHz, DMSO-d6) δ=8.57 (s, 1H), 8.48 (s, 1H), 8.29-8.25 (m, 1H), 8.23 (d, J=9.0 Hz, 1H), 8.19 (d, J=5.7 Hz, 1H), 7.95 (dd, J=1.8, 8.9 Hz, 1H), 7.57 (d, J=5.8 Hz, 1H), 7.35 (dt, J=6.5, 8.0 Hz, 1H), 7.25-7.16 (m, 2H), 7.08-6.97 (m, 2H), 3.79 (t, J=13.0 Hz, 2H), 3.21-3.10 (m, 1H), 3.08-2.91 (m, 2H), 2.09-1.99 (m, 1H), 1.97-1.83 (m, 2H), 1.79-1.65 (m, 1H). m/z (ESI) 464.2 (M+H)+.

後処理

  1. customthe reaction was flushed with argon
  2. additionThe reaction was diluted with ethyl acetate
  3. washwashed with water
  4. extractionThe aqueous layer was extracted with ethyl acetate
  5. dry with materialthe combined organic layers were dried with sodium sulfate
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe material was purified via column chromatography (RediSep Gold 40 g, gradient elution 0-10% MeOH:DCM)

出典と根拠

ORDレコード
ord-35caf521c8b94c709aac56e0a30a2de3
出典データセット
uspto-grants-2015_04
特許番号
US09012443B2

反応ノート

読み込み中…